$1.04
▼ $0.01 (-1.0%)
PLRX
Pliant Therapeutics, Inc.
Health Care
Investor Score
43D
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
12
Technical
50
Fundamental
71
Growth
43
Fair Value
50
News
47
Quality
62
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.